Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr 23;3(3):382-390.
doi: 10.1016/j.adro.2018.04.005. eCollection 2018 Jul-Sep.

Palliative radiation and fractionation in medicare patients with incurable non-small cell lung cancer

Miranda B Lam  1 , Ling Li  2 , Angel Cronin  2 , Deborah Schrag  2 , Aileen B Chen  1   2
Affiliations

Palliative radiation and fractionation in medicare patients with incurable non-small cell lung cancer

Miranda B Lam et al. Adv Radiat Oncol. .

Abstract

Purpose: Palliative radiation therapy (RT) can improve quality of life but also incurs time and financial costs. The aim of this study was to evaluate factors associated with use and intensity of palliative RT for incurable non-small cell lung cancer (NSCLC).

Methods and materials: This was a retrospective analysis of Medicare's Surveillance, Epidemiology and End Results data. We identified patients who were diagnosed with incurable (American Joint Committee on Cancer 6th edition stage IIIB with malignant effusion or stage IV) NSCLC between 2004 and 2011. Univariable and multivariable logistic regressions were used to identify factors associated with the receipt of palliative RT and the use of >10 fractions during the first course of radiation. Among patients who were treated with radiation, freestanding versus hospital-based center information was collected on the basis of the location of the RT delivery claim.

Results: Among 55,258 patients with incurable NSCLC, 38% (21,053 patients) received palliative RT during the first year after diagnosis. Among patients who received RT, 56% (11,717 patients) received >10 fractions. On multivariable analysis, factors associated with greater RT use included younger age group (overall P < .01), lower modified Charlson comorbidity score (overall P < .01), female sex (odds ratio [OR]: 1.1; P < .01), marital status (OR: 1.1; P < .01), and chemotherapy use (OR: 3.6; P < .01). Predictors for >10 fractions were chemotherapy use (OR: 1.7; P < .01) and treatment at a freestanding versus hospital-based facility (58% vs 43%; OR: 1.7; P < .01).

Conclusions: More than a third of patients diagnosed with incurable lung cancer receive palliative RT and 56% received >10 fractions. The use of RT varied by region and patient characteristics, and patients treated at freestanding RT centers were more likely to receive >10 fractions. Further research into factors that influence treatment decisions including potential financial incentives may contribute to the high value and strategic utilization of palliative RT.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart of cohort selection. NSCLC, non-small cell lung cancer.
Figure 2
Figure 2
Percent of patients with incurable non-small cell lung cancer who received conventional and stereotactic radiation therapy by year of diagnosis.
See this image and copyright information in PMC

References

    1. Howlader N., Noone A., Krapcho M. SEER cancer statistics review, 1975-2012. http://seer.cancer.gov/csr/1975_2012/ National Cancer Institute; Available at: based on November 2014 SEER data submission.
    1. Lutz S., Korytko T., Nguyen J., Khan L., Chow E., Corn B. Palliative radiotherapy: When is it worth it and when is it not? Cancer J. 2010;16:473–482. - PubMed
    1. Lutz S.T., Jones J., Chow E. Role of radiation therapy in palliative care of the patient with cancer. J Clin Oncol. 2014;32:2913–2919. - PMC - PubMed
    1. Chen A.B., Cronin A., Weeks J.C. Palliative radiation therapy practice in patients with metastatic non-small-cell lung cancer: A Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) Study. J Clin Oncol. 2013;31:558–564. - PMC - PubMed
    1. Bekelman J.E., Epstein A.J., Emanuel E.J. Single- vs multiple-fraction radiotherapy for bone metastases from prostate cancer. JAMA. 2013;310:1501–1502. - PMC - PubMed

LinkOut - more resources